Intellectus Partners, LLC Exact Sciences Corp Transaction History

Intellectus Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $209,826 - $279,018	-1,800 Closed	0 $0
Q4 2020 Feb 18, 2021	BUY	$99.61 - $142.12 $72,416 - $103,321	727 Added 67.75%	1,800 $238,000
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $106,881 - $152,494	1,073 New	1,073 $238,000
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $204,176 - $285,628	-2,800 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $156,100 - $259,700	2,800 New	2,800 $243,000
Q2 2019 Aug 08, 2019	SELL	$89.51 - $118.04 $44,755 - $59,020	-500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $30,990 - $48,250	500 New	500 $43,000
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $560,400 - $826,600	-10,000 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	10,000	10,000 $354,000

652

156M

1.43M

2.3M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.